Home/Filings/4/0000917520-24-000025
4//SEC Filing

De Witte Jan 4

Accession 0000917520-24-000025

CIK 0000917520other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 5:12 PM ET

Size

8.6 KB

Accession

0000917520-24-000025

Insider Transaction Report

Form 4
Period: 2024-03-10
De Witte Jan
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-10+34618,696 total
  • Tax Payment

    Common Stock

    2024-03-10$36.73/sh346$12,70918,350 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-1034689,071 total
    Exercise: $0.00Common Stock (346 underlying)
Footnotes (1)
  • [F1]The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/10/2023 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

Issuer

INTEGRA LIFESCIENCES HOLDINGS CORP

CIK 0000917520

Entity typeother

Related Parties

1
  • filerCIK 0001776929

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:12 PM ET
Size
8.6 KB